PharVision Advisers
AGNT icon

PharVision Advisers’s AGNT Inc AGNT Stock Holding History

PharVision Advisers’s Portfolio AGNT Stock Details AGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.1K Buy
+12,211
New +$67.3K 1.25% 50
2026
Q1 		– Sell
-43,765
Closed -$396K – 288
2025
Q4 		$396K Buy
+43,765
New +$462K 0.2% 130

Other funds holding AGNT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

PharVision Advisers's AGNT Position: Q2 2026 in Review

PharVision Advisers opened a new position in AGNT Inc (AGNT) in Q2 2026: 12,211 shares worth $66.1K. The stake represents 1.25% of the portfolio and ranks #50 among its holdings. This is a return to the name: PharVision Advisers previously reported a position in AGNT as recently as Q4 2025.

PharVision Advisers first reported a position in AGNT in Q4 2025 and has held it in 2 quarters since. The position peaked at $396K in Q4 2025. 241 funds tracked by Wall St. Rank hold AGNT as of Q2 2026.

  • PharVision Advisers held 12,211 shares of AGNT Inc worth $66.1K as of Q2 2026.
  • AGNT Inc was a new PharVision Advisers position in Q2 2026.
  • AGNT Inc made up 1.25% of PharVision Advisers's portfolio in Q2 2026, its #50 holding.
  • PharVision Advisers first reported a position in AGNT Inc in Q4 2025 and has held it in 2 quarters since.
  • PharVision Advisers's AGNT Inc position peaked at $396K in Q4 2025.
  • 241 funds tracked by Wall St. Rank held AGNT Inc as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.